Pardes Biosciences, Inc. Profile Avatar - Palmy Investing

Pardes Biosciences, Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 …

Biotechnology
US, Carlsbad [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Pardes Biosciences, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Pardes Biosciences, Inc. can't present revenue by segment

End of PRDS's Analysis
CIK: 1822711 CUSIP: 69945Q105 ISIN: US69945Q1058 LEI: - UEI: -
Secondary Listings
PRDS has no secondary listings inside our databases.